Research ArticleAlzheimer’s Disease

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

See allHide authors and affiliations

Science Translational Medicine  02 Nov 2016:
Vol. 8, Issue 363, pp. 363ra150
DOI: 10.1126/scitranslmed.aad9704

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article